Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    HOOKIPA Pharma Inc.

    NASDAQ: HOOK · Real-Time Price · USD
    1.42
    0.00 (0.00%)
    At close: Jun 16, 2025, 3:59 PM
    1.41
    -0.70%
    Pre-market: Jun 17, 2025, 08:18 AM EDT

    HOOKIPA Pharma Statistics

    Share Statistics

    HOOKIPA Pharma has 12.19M shares outstanding. The number of shares has increased by -87.51% in one year.

    Shares Outstanding

    n/a
    		 12.19M

    Shares Change (YoY)

    n/a
    		 -87.51%

    Shares Change (QoQ)

    n/a
    		 24.9%

    Owned by Institutions (%)

    n/a
    		 42.51%

    Shares Floating

    n/a
    		 8.69M

    Failed to Deliver (FTD) Shares

    n/a
    		 87

    FTD / Avg. Volume

    n/a
    		 0.08%

    Short Selling Information

    The latest short interest is 174.67K, so 1.43% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 174.67K

    Short % of Shares Out

    n/a
    		 1.43%

    Short % of Float

    n/a
    		 2.21%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.58 and the forward PE ratio is -0.67. HOOKIPA Pharma's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -0.58

    Forward PE

    n/a
    		 -0.67

    PS Ratio

    n/a
    		 0.57

    Forward PS

    n/a
    		 0.9

    PB Ratio

    n/a
    		 0.49

    P/FCF Ratio

    n/a
    		 -0.33

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for HOOKIPA Pharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.27, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 3.27

    Quick Ratio

    n/a
    		 3.27

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 -25727.5

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $535,926.83

    Profits Per Employee

    n/a
    		 $-530,524.39

    Employee Count

    n/a
    		 82

    Asset Turnover

    n/a
    		 0.53

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -106K

    Effective Tax Rate

    n/a
    		 0.24%

    Stock Price Statistics

    The stock price has increased by -80.11% in the last 52 weeks. The beta is 0.94, so HOOKIPA Pharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.94

    52-Week Price Change

    n/a
    		 -80.11%

    50-Day Moving Average

    n/a
    		 1.25

    200-Day Moving Average

    n/a
    		 2.36

    Relative Strength Index (RSI)

    n/a
    		 51.52

    Average Volume (20 Days)

    n/a
    		 113,960

    Income Statement

    In the last 12 months, HOOKIPA Pharma had revenue of 43.95M and earned -43.5M in profits. Earnings per share was -3.47.

    Revenue

    n/a
    		 43.95M

    Gross Profit

    n/a
    		 43.95M

    Operating Income

    n/a
    		 -51.45M

    Net Income

    n/a
    		 -43.5M

    EBITDA

    n/a
    		 -40.85M

    EBIT

    n/a
    		 -43.61M

    Earnings Per Share (EPS)

    n/a
    		 -3.47
    Full Income Statement

    Balance Sheet

    The company has 39.68M in cash and 875K in debt, giving a net cash position of 38.81M.

    Cash & Cash Equivalents

    n/a
    		 39.68M

    Total Debt

    n/a
    		 875K

    Net Cash

    n/a
    		 38.81M

    Retained Earnings

    n/a
    		 -412.76M

    Total Assets

    n/a
    		 61.26M

    Working Capital

    n/a
    		 43.45M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -76.98M and capital expenditures -194K, giving a free cash flow of -77.17M.

    Operating Cash Flow

    n/a
    		 -76.98M

    Capital Expenditures

    n/a
    		 -194K

    Free Cash Flow

    n/a
    		 -77.17M

    FCF Per Share

    n/a
    		 -6.15
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -117.09% and -98.99%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -117.09%

    Pretax Margin

    n/a
    		 -99.23%

    Profit Margin

    n/a
    		 -98.99%

    EBITDA Margin

    n/a
    		 -92.96%

    EBIT Margin

    n/a
    		 -117.09%

    FCF Margin

    n/a
    		 -175.61%

    Dividends & Yields

    HOOK does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for HOOK is $4.5, which is 216.9% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $4.5

    Price Target Difference

    n/a
    		 216.9%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jul 10, 2024. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Jul 10, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -12.48

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist